Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Sponsor: Novartis Pharmaceuticals
Summary
This observational prospective study aims to evaluate the LDL-C change and adherence to inclisiran in combination with other lipid lowering therapies or lipid lowering treatments (LLTs) under conditions of routine clinical practice.
Official title: VICTORION REAL: An International Prospective Real-world Study to Evaluate the LDL-C changE and Adherence to incLisiran in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
847
Start Date
2022-09-12
Completion Date
2026-10-05
Last Updated
2026-02-03
Healthy Volunteers
No
Interventions
Inclisiran
Prospective observational study. There is no treatment allocation. Patients who are eligible to receive inclisiran will be enrolled into this study.
Locations (40)
Novartis Investigative Site
Feldkirch, Austria
Novartis Investigative Site
Graz, Austria
Novartis Investigative Site
Linz, Austria
Novartis Investigative Site
Sankt Veit im Pongau, Austria
Novartis Investigative Site
Vienna, Austria
Novartis Investigative Site
Vienna, Austria
Novartis Investigative Site
Shenzhen, Guangdong, China
Novartis Investigative Site
Holon, Gush Dan, Israel
Novartis Investigative Site
Petah Tikva, Israel
Novartis Investigative Site
Tel Aviv, Israel
Novartis Investigative Site
Kuala Lumpur, Kuala Lumpur, Malaysia
Novartis Investigative Site
Kuala Lumpur, Malaysia
Novartis Investigative Site
Riyadh, Saudi, Saudi Arabia
Novartis Investigative Site
Jeddah, Saudi Arabia
Novartis Investigative Site
Tabuk, Saudi Arabia
Novartis Investigative Site
Fribourg, CH, Switzerland
Novartis Investigative Site
Basel, Switzerland
Novartis Investigative Site
Geneva, Switzerland
Novartis Investigative Site
Lausanne, Switzerland
Novartis Investigative Site
Olten, Switzerland
Novartis Investigative Site
Sankt Gallen, Switzerland
Novartis Investigative Site
Zurich, Switzerland
Novartis Investigative Site
Zurich, Switzerland
Novartis Investigative Site
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Novartis Investigative Site
Dubai, United Arab Emirates, United Arab Emirates
Novartis Investigative Site
Abu Dhabi, United Arab Emirates
Novartis Investigative Site
Al Ain City, United Arab Emirates
Novartis Investigative Site
Dubai, United Arab Emirates
Novartis Investigative Site
High Wycombe, Buckinghamshire, United Kingdom
Novartis Investigative Site
Louth, Lincolnshire, United Kingdom
Novartis Investigative Site
Sunderland, Tyne and Wear, United Kingdom
Novartis Investigative Site
Belfast, United Kingdom
Novartis Investigative Site
Bromwich, United Kingdom
Novartis Investigative Site
Burton-on-Trent, United Kingdom
Novartis Investigative Site
Cardiff, United Kingdom
Novartis Investigative Site
Hull, United Kingdom
Novartis Investigative Site
Lancaster, United Kingdom
Novartis Investigative Site
Liverpool, United Kingdom
Novartis Investigative Site
London, United Kingdom
Novartis Investigative Site
Middlesex, United Kingdom